Using osteogenic medium in the in vitro evaluation of bone biomaterials: Artefacts due to a synergistic effect

Biochimie. 2024 Jan:216:24-33. doi: 10.1016/j.biochi.2023.09.015. Epub 2023 Sep 15.

Abstract

In vitro tests using bone cells to evaluate the osteogenic potential of biomaterials usually employ the osteogenic medium (OM). The lack of correlation frequently reported between in vitro and in vivo studies in bone biomaterials, makes necessary the evaluation of the impact of osteogenic supplements on these results. This study analysed the proteomic profiles of human osteoblasts (HOb) cultured in the media with and without osteogenic agents (ascorbic acid and β-glycerol phosphate). The cells were incubated for 1 and 7 days, on their own or in contact with Ti. The comparative Perseus analysis identified 2544 proteins whose expression was affected by osteogenic agents. We observed that the OM strongly alters protein expression profiles with a complex impact on multiple pathways associated with adhesion, immunity, oxidative stress, coagulation, angiogenesis and osteogenesis. OM-triggered changes in the HOb intracellular energy production mechanisms, with key roles in osteoblast maturation. HOb cultured with and without Ti showed enrichment in the skeletal system development function due to the OM. However, differentially expressed proteins with key regenerative functions were associated with a synergistic effect of OM and Ti. This synergy, caused by the Ti-OM interaction, could complicate the interpretation of in vitro results, highlighting the need to analyse this phenomenon in biomaterial testing.

Keywords: Ascorbic acid; Cell protein expression; Cell–material interaction; Dental implants; Osteoblasts; Osteogenesis.

MeSH terms

  • Artifacts*
  • Biocompatible Materials / metabolism
  • Biocompatible Materials / pharmacology
  • Bone and Bones
  • Cell Differentiation
  • Humans
  • Osteoblasts
  • Osteogenesis*
  • Proteomics

Substances

  • Biocompatible Materials